{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:09:02Z","timestamp":1785283742570,"version":"3.55.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The National Science Fund for Distinguished Young Scholars","award":["81425005"],"award-info":[{"award-number":["81425005"]}]},{"name":"The Key Project of the National Natural Science Foundation","award":["81330005 and 81630011"],"award-info":[{"award-number":["81330005 and 81630011"]}]},{"name":"The National Science and Technology Support Project","award":["2014BAI02B01 and 2015BAI08B01"],"award-info":[{"award-number":["2014BAI02B01 and 2015BAI08B01"]}]},{"name":"The National Key Research and Development Program","award":["2013YQ030923-05"],"award-info":[{"award-number":["2013YQ030923-05"]}]},{"name":"The Key Collaborative Project of the National Natural Science Foundation","award":["91639304"],"award-info":[{"award-number":["91639304"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00109-019-01765-1","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T23:02:50Z","timestamp":1553036570000},"page":"593-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Innate immune regulatory networks in hepatic lipid metabolism"],"prefix":"10.1007","volume":"97","author":[{"given":"Lan","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"issue":"1\u20132","key":"1765_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mce.2013.06.002","volume":"379","author":"C Koliaki","year":"2013","unstructured":"Koliaki C, Roden M (2013) Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol 379(1\u20132):35\u201342","journal-title":"Mol Cell Endocrinol"},{"issue":"44","key":"1765_CR2","doi-asserted-by":"publisher","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","volume":"22","author":"A Lonardo","year":"2016","unstructured":"Lonardo A, Ballestri S, Guaraldi G, Nascimbeni F, Romagnoli D, Zona S, Targher G (2016) Fatty liver is associated with an increased risk of diabetes and cardiovascular disease\u2014evidence from three different disease models: NAFLD, HCV and HIV. World J Gastroenterol 22(44):9674\u20139693","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1765_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A (2016) Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol 31(5):936\u2013944","journal-title":"J Gastroenterol Hepatol"},{"key":"1765_CR4","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","volume":"23","author":"S Singh","year":"2017","unstructured":"Singh S, Osna NA, Kharbanda KK, Singh S, Osna NA, Kharbanda KK (2017) Treatment options for alcoholic and non-alcoholic fatty liver disease: a review. World J Gastroenterol 23:6549\u20136570","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1765_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cld.2015.10.009","volume":"20","author":"S Ganesh","year":"2016","unstructured":"Ganesh S, Rustgi VK (2016) Current pharmacologic therapy for nonalcoholic fatty liver disease. Clin Liver Dis 20(2):351\u2013364","journal-title":"Clin Liver Dis"},{"key":"1765_CR6","unstructured":"Byun JS, Yi HS (2017) Hepatic immune microenvironment in alcoholic and nonalcoholic liver disease. Biomed Res Int 2017:6862439"},{"issue":"10","key":"1765_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.tem.2018.08.003","volume":"29","author":"J Cai","year":"2018","unstructured":"Cai J, Zhang XJ, Li H (2018) Role of innate immune signaling in non-alcoholic fatty liver disease. Trends Endocrinol Metab 29(10):712\u2013722","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"1765_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52(2):774\u2013788","journal-title":"Hepatology"},{"issue":"4","key":"1765_CR9","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56(4):952\u2013964","journal-title":"J Hepatol"},{"issue":"6","key":"1765_CR10","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00125-016-3940-5","volume":"59","author":"JG Jones","year":"2016","unstructured":"Jones JG (2016) Hepatic glucose and lipid metabolism. Diabetologia 59(6):1098\u20131103","journal-title":"Diabetologia"},{"issue":"4","key":"1765_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.28985","volume":"65","author":"F Bril","year":"2017","unstructured":"Bril F, Barb D, Portillo-Sanchez P, Biernacki D, Lomonaco R, Suman A, Weber MH, Budd JT, Lupi ME, Cusi K (2017) Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology 65(4):1132\u20131144","journal-title":"Hepatology"},{"issue":"11","key":"1765_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2(11):901\u2013910","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1765_CR13","first-page":"676","volume":"62","author":"M Sochocka","year":"2008","unstructured":"Sochocka M (2008) Recognition of pathogens by innate immunity. Postepy Hig Med Dosw 62:676\u2013687","journal-title":"Postepy Hig Med Dosw"},{"issue":"4","key":"1765_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/myc.12052","volume":"56","author":"C Lass-Fl\u00f6rl","year":"2013","unstructured":"Lass-Fl\u00f6rl C, Roilides E, L\u00f6ffler J, Wilflingseder D, Romani L (2013) Minireview: host defence in invasive aspergillosis. Mycoses 56(4):403\u2013413","journal-title":"Mycoses"},{"issue":"2","key":"1765_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1189\/jlb.0510250","volume":"89","author":"C Costantini","year":"2011","unstructured":"Costantini C, Cassatella MA (2011) The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. J Leukoc Biol 89(2):221\u2013233","journal-title":"J Leukoc Biol"},{"issue":"3","key":"1765_CR16","first-page":"303","volume":"28","author":"GC Xie","year":"2012","unstructured":"Xie GC, Duan ZJ (2012) Signal transduction of innate immunity to virus infection. Bing Du Xue Bao 28(3):303\u2013310","journal-title":"Bing Du Xue Bao"},{"issue":"9","key":"1765_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur JS, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13(9):679\u2013692","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1765_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.R067595","volume":"57","author":"J Han","year":"2016","unstructured":"Han J, Kaufman RJ (2016) The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res 57(8):1329\u20131338","journal-title":"J Lipid Res"},{"issue":"2","key":"1765_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","volume":"134","author":"P Puri","year":"2008","unstructured":"Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, Sanyal AJ (2008) Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 134(2):568\u2013576","journal-title":"Gastroenterology"},{"issue":"7","key":"1765_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","volume":"12","author":"G Szabo","year":"2015","unstructured":"Szabo G, Petrasek J (2015) Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol 12(7):387\u2013400","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1765_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G (2011) Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54(1):133\u2013144","journal-title":"Hepatology"},{"issue":"1","key":"1765_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama Y, Brenner DA (2017) Liver inflammation and fibrosis. J Clin Invest 127(1):55\u201364","journal-title":"J Clin Invest"},{"issue":"12","key":"1765_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.tem.2017.10.007","volume":"28","author":"A Lawan","year":"2017","unstructured":"Lawan A, Bennett AM (2017) Mitogen-activated protein kinase regulation in hepatic metabolism. Trends Endocrinol Metab 28(12):868\u2013878","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"1765_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/13813455.2014.973418","volume":"120","author":"B Knebel","year":"2014","unstructured":"Knebel B, Lehr S, Hartwig S, Haas J, Kaber G, Dicken HD, Susanto F, Bohne L, Jacob S, Nitzgen U, Passlack W, Muller-Wieland D, Kotzka J (2014) Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2. Arch Physiol Biochem 120(5):216\u2013227","journal-title":"Arch Physiol Biochem"},{"issue":"1\u20132","key":"1765_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.mce.2013.05.021","volume":"375","author":"P Jiao","year":"2013","unstructured":"Jiao P, Feng B, Li Y, He Q, Xu H (2013) Hepatic ERK activity plays a role in energy metabolism. Mol Cell Endocrinol 375(1\u20132):157\u2013166","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1765_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.trsl.2015.08.011","volume":"167","author":"H Khodabandeloo","year":"2016","unstructured":"Khodabandeloo H, Gorganifiruzjaee S, Panahi S, Meshkani R (2016) Molecular and cellular mechanisms linking inflammation to insulin resistance and \u03b2-cell dysfunction. Transl Res 167(1):228\u2013256","journal-title":"Transl Res"},{"issue":"6","key":"1765_CR27","first-page":"377","volume":"3","author":"V Bieghs","year":"2014","unstructured":"Bieghs V, Trautwein C (2014) Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 3(6):377\u2013385","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"6","key":"1765_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805\u2013820","journal-title":"Cell"},{"issue":"1","key":"1765_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00125-010-1931-5","volume":"54","author":"LH Kuo","year":"2011","unstructured":"Kuo LH, Tsai PJ, Jiang MJ, Chuang YL, Yu L, Lai KTA, Tsai YS (2011) Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Diabetologia 54(1):168\u2013179","journal-title":"Diabetologia"},{"key":"1765_CR30","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1038\/ncomms4878","volume":"5","author":"L Jia","year":"2014","unstructured":"Jia L, Vianna CR, Fukuda M, Berglund ED, Liu C, Tao C, Sun K, Liu T, Harper MJ, Lee CE, Lee S, Scherer PE, Elmquist JK (2014) Hepatocyte toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance. Nat Commun 5:3878","journal-title":"Nat Commun"},{"issue":"8","key":"1765_CR31","first-page":"1509","volume":"35","author":"S Inokuchi","year":"2011","unstructured":"Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E (2011) Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res 35(8):1509\u20131518","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"1765_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.chom.2012.07.004","volume":"12","author":"FA Carvalho","year":"2012","unstructured":"Carvalho FA, Koren O, Goodrich JK, Johansson ME, Nalbantoglu I, Aitken JD et al (2012) Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 12(2):139\u2013152","journal-title":"Cell Host Microbe"},{"issue":"6","key":"1765_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.cmet.2015.09.028","volume":"22","author":"V Singh","year":"2015","unstructured":"Singh V, Chassaing B, Zhang L, San YB, Xiao X, Kumar M et al (2015) Microbiota-dependent hepatic lipogenesis mediated by stearoyl CoA desaturase 1 (SCD1) promotes metabolic syndrome in TLR5-deficient mice. Cell Metab 22(6):983\u2013996","journal-title":"Cell Metab"},{"key":"1765_CR34","doi-asserted-by":"publisher","unstructured":"Arias-Loste MT, Iruzubieta P, Puente \u00c1, Ramos D, Santa Cruz C, Est\u00e9banez \u00c1, Llerena S, Alonso-Mart\u00edn C, San Segundo D, \u00c1lvarez L, L\u00f3pez Useros A, F\u00e1brega E, L\u00f3pez-Hoyos M, Crespo J (2016) Increased expression profile and functionality of TLR6 in peripheral blood mononuclear cells and hepatocytes of morbidly obese patients with non-alcoholic fatty liver disease. Int J Mol Sci 17(11). \n                    https:\/\/doi.org\/10.3390\/ijms17111878","DOI":"10.3390\/ijms17111878"},{"issue":"1","key":"1765_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139(1):323\u2013334","journal-title":"Gastroenterology"},{"issue":"31","key":"1765_CR36","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.3748\/wjg.v22.i31.6965","volume":"22","author":"P Handa","year":"2016","unstructured":"Handa P, Vemulakonda A, Kowdley KV, Uribe M, M\u00e9ndez-S\u00e1nchez N (2016) Mitochondrial DNA from hepatocytes as a ligand for TLR9: drivers of nonalcoholic steatohepatitis? World J Gastroenterol 22(31):6965\u20136971","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1765_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI83885","volume":"126","author":"I Garcia-Martinez","year":"2016","unstructured":"Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, Shlomchik MJ, Coffman RL, Candia A, Mehal WZ (2016) Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest 126(3):859\u2013864","journal-title":"J Clin Invest"},{"issue":"3","key":"1765_CR38","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/jcp.25930","volume":"233","author":"Z Hoseini","year":"2017","unstructured":"Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H (2017) NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol 233(3):2116\u20132132","journal-title":"J Cell Physiol"},{"issue":"10","key":"1765_CR39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","volume":"92","author":"A Wree","year":"2014","unstructured":"Wree A, Mcgeough MD, Pe\u00f1a CA, Schlattjan M, Li H, Inzaugarat ME et al (2014) NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med 92(10):1069\u20131082","journal-title":"J Mol Med"},{"issue":"5","key":"1765_CR40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM et al (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66(5):1037\u20131046","journal-title":"J Hepatol"},{"issue":"7384","key":"1765_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384):179\u2013185","journal-title":"Nature"},{"issue":"6","key":"1765_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nri3446","volume":"13","author":"LA O'Neill","year":"2013","unstructured":"O'Neill LA, Golenbock D, Bowie AG (2013) The history of toll-like receptors [mdash] redefining innate immunity. Nat Rev Immunol 13(6):453\u2013460","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1765_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jcmgh.2016.12.004","volume":"3","author":"L Yang","year":"2017","unstructured":"Yang L, Miura K, Zhang B, Matsushita H, Yang YM, Liang S, Song J, Roh YS, Seki E (2017) TRIF differentially regulates hepatic steatosis and inflammation\/fibrosis in mice. Cell Mol Gastroenterol Hepatol 3(3):469\u2013483","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"1765_CR44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/gutjnl-2015-310904","volume":"66","author":"T Duparc","year":"2016","unstructured":"Duparc T, Plovier H, Marrachelli VG, Hul MV, Essaghir A, St\u00e5hlman M et al (2016) Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. Gut 66(4):620\u2013632","journal-title":"Gut"},{"key":"1765_CR45","doi-asserted-by":"crossref","unstructured":"Castoldi A, Andrade-Oliveira V, Aguiar CF, Amano MT, Lee J, Miyagi MT et al (2017) Dectin-1 activation exacerbates obesity and insulin resistance in the absence of MyD88. Cell Rep 19(11):2272\u20132288","DOI":"10.1016\/j.celrep.2017.05.059"},{"key":"1765_CR46","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/ncomms6648","volume":"5","author":"A Everard","year":"2014","unstructured":"Everard A, Geurts L, Caesar R, Van Hul M, Matamoros S, Duparc T et al (2014) Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun 5:5648","journal-title":"Nat Commun"},{"issue":"3","key":"1765_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bbrc.2015.09.165","volume":"467","author":"W Zhang","year":"2015","unstructured":"Zhang W, Tang Z, Zhu X, Xia N, Zhao Y, Wang S, Cui S, Wang C (2015) TRAF1 knockdown alleviates palmitate-induced insulin resistance in HepG2 cells through NF-\u03baB pathway. Biochem Biophys Res Commun 467(3):527\u2013533","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1765_CR48","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jhep.2016.02.002","volume":"64","author":"M Xiang","year":"2016","unstructured":"Xiang M, Wang PX, Wang AB, Zhang XJ, Zhang Y, Zhang P, Mei FH, Chen MH, Li H (2016) Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis. J Hepatol 64(6):1365\u20131377","journal-title":"J Hepatol"},{"issue":"12","key":"1765_CR49","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molmet.2015.09.013","volume":"4","author":"Z Chen","year":"2015","unstructured":"Chen Z, Canet MJ, Liang S, Jiang L, Xiong Y, Yin L, Rui L (2015) Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity. Mol Metab 4(12):951\u2013960","journal-title":"Mol Metab"},{"issue":"6","key":"1765_CR50","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1152\/ajpendo.00470.2014","volume":"308","author":"Z Chen","year":"2015","unstructured":"Chen Z, Shen H, Sun C, Yin L, Tang F, Zheng P et al (2015) Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. Am J Physiol Endocrinol Metab 308(6):460\u2013469","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1765_CR51","doi-asserted-by":"crossref","unstructured":"Chatzigeorgiou A, Seijkens T, Zarzycka B, Engel D, Poggi M, van den Berg S et al (2014) Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proc Natl Acad Sci U S A 111(7):2686\u20132691","DOI":"10.1073\/pnas.1400419111"},{"issue":"1","key":"1765_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2016.03.006","volume":"65","author":"L Gao","year":"2016","unstructured":"Gao L, Wang PX, Zhang Y, Yu CJ, Ji Y, Wang X, Zhang P, Jiang X, Jin H, Huang Z, Zhang ZR, Li H (2016) Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis. J Hepatol 65(1):125\u2013136","journal-title":"J Hepatol"},{"issue":"2","key":"1765_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1051\/jbio\/2014014","volume":"208","author":"F Ceppo","year":"2014","unstructured":"Ceppo F, Jager J, Berthou F, Giorgetti-Peraldi S, Cormont M, Bost F, Tanti JF (2014) Implication of MAP kinases in obesity-induced inflammation and insulin resistance. Biol Aujourdhui 208(2):97\u2013107","journal-title":"Biol Aujourdhui"},{"issue":"32","key":"1765_CR54","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.2174\/1381612811319320009","volume":"19","author":"S Kumphune","year":"2013","unstructured":"Kumphune S, Chattipakorn S, Chattipakorn N (2013) Roles of p38-MAPK in insulin resistant heart: evidence from bench to future bedside application. Curr Pharm Des 19(32):5742\u20135754","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1765_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2337\/db10-0628","volume":"60","author":"HS Kang","year":"2011","unstructured":"Kang HS, Okamoto K, Kim YS, Takeda Y, Bortner CD, Dang H, Wada T, Xie W, Yang XP, Liao G, Jetten AM (2011) Nuclear orphan receptor TAK1\/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance. Diabetes 60(1):177\u2013188","journal-title":"Diabetes"},{"issue":"4","key":"1765_CR56","doi-asserted-by":"publisher","DOI":"10.4161\/23723548.2014.968507","volume":"1","author":"E Seki","year":"2014","unstructured":"Seki E (2014) TAK1-dependent autophagy: a suppressor of fatty liver disease and hepatic oncogenesis. Mol Cell Oncol 1(4):e968507","journal-title":"Mol Cell Oncol"},{"key":"1765_CR57","doi-asserted-by":"crossref","unstructured":"Inokuchi-Shimizu S, Park EJ, Roh YS, Yang L, Zhang B, Song J et al (2014) TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. J Clin Invest 124(8):3566\u20133578","DOI":"10.1172\/JCI74068"},{"issue":"29","key":"1765_CR58","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1038\/onc.2015.453","volume":"35","author":"S Morioka","year":"2016","unstructured":"Morioka S, Sai K, Omori E, Ikeda Y, Matsumoto K, Ninomiya-Tsuji J (2016) TAK1 regulates hepatic lipid homeostasis through SREBP. Oncogene 35(29):3829\u20133838","journal-title":"Oncogene"},{"issue":"6","key":"1765_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrgastro.2017.42","volume":"14","author":"S Schuster","year":"2017","unstructured":"Schuster S, Feldstein AE (2017) NASH: novel therapeutic strategies targeting ASK1 in NASH. Nat Rev Gastroenterol Hepatol 14(6):329\u2013330","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1765_CR60","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.108.112292","volume":"52","author":"E Yamamoto","year":"2008","unstructured":"Yamamoto E, Dong YF, Kataoka K, Yamashita T, Tokutomi Y, Matsuba S, Ichijo H, Ogawa H, Kim-Mitsuyama S (2008) Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition. Hypertension 52(3):573\u2013580","journal-title":"Hypertension"},{"issue":"3","key":"1765_CR61","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/hep.29257","volume":"66","author":"QY Zhang","year":"2017","unstructured":"Zhang QY, Zhao LP, Tian XX, Yan CH, Li Y, Liu YX, Wang PX, Zhang XJ, Han YL (2017) The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance. Hepatology 66(3):834\u2013854","journal-title":"Hepatology"},{"issue":"1","key":"1765_CR62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jhep.2016.03.008","volume":"65","author":"L Xie","year":"2016","unstructured":"Xie L, Wang PX, Zhang P, Zhang XJ, Zhao GN, Wang A, Guo J, Zhu X, Zhang Q, Li H (2016) DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity. J Hepatol 65(1):113\u2013124","journal-title":"J Hepatol"},{"issue":"1","key":"1765_CR63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/hep.20999","volume":"43","author":"JM Schattenberg","year":"2006","unstructured":"Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ (2006) JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43(1):163\u2013172","journal-title":"Hepatology"},{"issue":"12","key":"1765_CR64","first-page":"948","volume":"22","author":"Y Hu","year":"2014","unstructured":"Hu Y, Peng N, Lei D, Cheng F, Chen Y (2014) Impact of JNK inhibitor XG-102 in a diet-induced rat model of non-alcoholic steatohepatitis. Zhonghua Gan Zang Bing Za Zhi 22(12):948\u2013952","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"1765_CR65","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/mmr.2016.5966","volume":"15","author":"H Yan","year":"2017","unstructured":"Yan H, Gao Y, Zhang Y (2017) Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease. Mol Med Rep 15(1):180\u2013186","journal-title":"Mol Med Rep"},{"key":"1765_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.11","volume":"6","author":"S Pereira","year":"2016","unstructured":"Pereira S, Yu WQ, Moore J, Mori Y, Tsiani E, Giacca A (2016) Effect of a p38 MAPK inhibitor on FFA-induced hepatic insulin resistance in vivo. Nutr Diabetes 6:e210","journal-title":"Nutr Diabetes"},{"issue":"10","key":"1765_CR67","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/nm.2449","volume":"17","author":"J Lee","year":"2011","unstructured":"Lee J, Sun C, Zhou Y, Lee J, Gokalp D, Herrema H, Park SW, Davis RJ, Ozcan U (2011) p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis. Nat Med 17(10):1251\u20131260","journal-title":"Nat Med"},{"issue":"4","key":"1765_CR68","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000361","volume":"2","author":"T Kujiraoka","year":"2013","unstructured":"Kujiraoka T, Satoh Y, Ayaori M, Shiraishi Y, Arainakaya Y, Hakuno D et al (2013) Hepatic extracellular signal\u2013regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunction. J Am Heart Assoc 2(4):e000361","journal-title":"J Am Heart Assoc"},{"key":"1765_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biochi.2017.03.004","volume":"137","author":"AS Khan","year":"2017","unstructured":"Khan AS, Subramaniam S, Dramane G, Khelifi D, Khan NA (2017) ERK1 and ERK2 activation modulates diet-induced obesity in mice. Biochimie 137:78\u201387","journal-title":"Biochimie"},{"issue":"5","key":"1765_CR70","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/hep.28433","volume":"63","author":"PX Wang","year":"2016","unstructured":"Wang PX, Zhang XJ, Li H (2016) Liver capsule: IRFs in hepatocytes: pathophysiology. Hepatology 63(5):1706","journal-title":"Hepatology"},{"issue":"2","key":"1765_CR71","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbadis.2014.04.030","volume":"1852","author":"GN Zhao","year":"2015","unstructured":"Zhao GN, Jiang DS, Li H (2015) Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. Biochim Biophys Acta 1852(2):365\u2013378","journal-title":"Biochim Biophys Acta"},{"issue":"491","key":"1765_CR72","doi-asserted-by":"publisher","first-page":"eaal3336","DOI":"10.1126\/scisignal.aal3336","volume":"10","author":"J Chen","year":"2017","unstructured":"Chen J, Li J, Yiu JHC, Lam JKW, Wong CM, Dorweiler B, Xu A, Woo CW (2017) TRIF-dependent toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis. Sci Signal 10(491):eaal3336","journal-title":"Sci Signal"},{"issue":"3","key":"1765_CR73","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/hep.26751","volume":"59","author":"XA Wang","year":"2014","unstructured":"Wang XA, Zhang R, She ZG, Zhang XF, Jiang DS, Wang T, Gao L, Deng W, Zhang SM, Zhu LH, Guo S, Chen K, Zhang XD, Liu DP, Li H (2014) Interferon regulatory factor 3 constrains IKK\u03b2\/NF-\u03baB signaling to alleviate hepatic steatosis and insulin resistance. Hepatology 59(3):870\u2013885","journal-title":"Hepatology"},{"issue":"8","key":"1765_CR74","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1172\/JCI86080","volume":"126","author":"M Kumari","year":"2016","unstructured":"Kumari M, Wang X, Lantier L, Lyubetskaya A, Eguchi J, Kang S, Tenen D, Roh HC, Kong X, Kazak L, Ahmad R, Rosen ED (2016) IRF3 promotes adipose inflammation and insulin resistance and represses browning. J Clin Invest 126(8):2839\u20132854","journal-title":"J Clin Invest"},{"issue":"4","key":"1765_CR75","doi-asserted-by":"publisher","first-page":"E485","DOI":"10.1152\/ajpendo.00505.2012","volume":"305","author":"XA Wang","year":"2013","unstructured":"Wang XA, Zhang R, Zhang S, Deng S, Jiang D, Zhong J, Yang L, Wang T, Hong S, Guo S, She ZG, Zhang XD, Li H (2013) Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab 305(4):E485\u2013E495","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"1765_CR76","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/hep.26368","volume":"58","author":"XA Wang","year":"2013","unstructured":"Wang XA, Zhang R, Jiang D, Deng W, Zhang S, Deng S, Zhong J, Wang T, Zhu LH, Yang L, Hong S, Guo S, Chen K, Zhang XF, She Z, Chen Y, Yang Q, Zhang XD, Li H (2013) Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology 58(2):603\u2013616","journal-title":"Hepatology"},{"issue":"10","key":"1765_CR77","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","volume":"5","author":"V Z\u00e1mb\u00f3","year":"2013","unstructured":"Z\u00e1mb\u00f3 V, Simon-Szab\u00f3 L, Szel\u00e9nyi P, Kereszturi E, B\u00e1nhegyi G, Csala M (2013) Lipotoxicity in the liver. World J Hepatol 5(10):550\u2013557","journal-title":"World J Hepatol"},{"issue":"8","key":"1765_CR78","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","volume":"18","author":"D Pal","year":"2012","unstructured":"Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18(8):1279\u20131285","journal-title":"Nat Med"},{"issue":"6","key":"1765_CR79","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/nm.4334","volume":"23","author":"GN Zhao","year":"2017","unstructured":"Zhao GN, Zhang P, Gong J, Zhang XJ, Wang PX, Yin M, Jiang Z, Shen LJ, Ji YX, Tong J, Wang Y, Wei QF, Wang Y, Zhu XY, Zhang X, Fang J, Xie Q, She ZG, Wang Z, Huang Z, Li H (2017) Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4. Nat Med 23(6):742\u2013752","journal-title":"Nat Med"},{"issue":"4","key":"1765_CR80","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nm.4290","volume":"23","author":"PX Wang","year":"2017","unstructured":"Wang PX, Ji YX, Zhang XJ, Zhao LP, Yan ZZ, Zhang P, Shen LJ, Yang X, Fang J, Tian S, Zhu XY, Gong J, Zhang X, Wei QF, Wang Y, Li J, Wan L, Xie Q, She ZG, Wang Z, Huang Z, Li H (2017) Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. Nat Med 23(4):439\u2013449","journal-title":"Nat Med"},{"issue":"1","key":"1765_CR81","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nm.4453","volume":"24","author":"P Zhang","year":"2018","unstructured":"Zhang P, Wang PX, Zhao LP, Zhang X, Ji YX, Zhang XJ, Fang C, Lu YX, Yang X, Gao MM, Zhang Y, Tian S, Zhu XY, Gong J, Ma XL, Li F, Wang Z, Huang Z, She ZG, Li H (2018) The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis. Nat Med 24(1):84\u201394","journal-title":"Nat Med"},{"issue":"6","key":"1765_CR82","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/hep.29375","volume":"66","author":"S An","year":"2017","unstructured":"An S, Zhao LP, Shen LJ, Wang S, Zhang K, Qi Y, Zheng J, Zhang XJ, Zhu XY, Bao R, Yang L, Lu YX, She ZG, Tang YD (2017) USP18 protects against hepatic steatosis and insulin resistance via its DUB activity. Hepatology 66(6):1866\u20131884","journal-title":"Hepatology"},{"issue":"2","key":"1765_CR83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm.4461","volume":"24","author":"YX Ji","year":"2018","unstructured":"Ji YX, Huang Z, Yang X, Wang X, Zhao LP, Wang PX, Zhang XJ, Alves-Bezerra M, Cai L, Zhang P, Lu YX, Bai L, Gao MM, Zhao H, Tian S, Wang Y, Huang ZX, Zhu XY, Zhang Y, Gong J, She ZG, Li F, Cohen DE, Li H (2018) The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. Nat Med 24(2):213\u2013223","journal-title":"Nat Med"},{"issue":"5","key":"1765_CR84","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/hep.28971","volume":"65","author":"FJ Yan","year":"2017","unstructured":"Yan FJ, Zhang XJ, Wang WX, Ji YX, Wang PX, Yang Y, Gong J, Shen LJ, Zhu XY, Huang Z, Li H (2017) The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. Hepatology 65(5):1492\u20131511","journal-title":"Hepatology"},{"key":"1765_CR85","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1038\/ncomms10592","volume":"7","author":"PX Wang","year":"2016","unstructured":"Wang PX, Zhang XJ, Luo P, Jiang X, Zhang P, Guo J, Zhao GN, Zhu X, Zhang Y, Yang S, Li H (2016) Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. Nat Commun 7:10592","journal-title":"Nat Commun"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01765-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:05:51Z","timestamp":1584489951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01765-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01765-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"4 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}